Diabetic gastroparesis is a diabetes complication in which the stomach muscles stop working well or at all, slowing down how quickly food leaves your stomach to your intestine. It can make you ...

Early diagnosis and management are vital to improving quality of life, as the condition can significantly impact nutritional ...

the stimulator received FDA approval as a humanitarian use device and was granted a humanitarian device exemption for application in patients with diabetic and idiopathic gastroparesis.

Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the ...

A survey in 2023 indicated that seven out of 10 urban Indians suffer from gut health problems. Experts do not rule out many of these issues being linked to high blood sugar levels in individuals. Dr ...

Diabetes can lead to complications throughout the body and commonly causes digestive disorders such as gastroparesis (delayed emptying of the stomach). This can lead to stomach problems and pain.

McCallum and colleagues studied whether mitemcinal, an orally administered motilin agonist, is effective at improving diabetes-related gastroparesis symptoms. The authors conclude that mitemcinal ...

Jessie Sharp, 29, has gastroparesis which means she can’t process food properly and has to rely on a feeding tube and gastric ...

Gastroparesis is most commonly associated with diabetes, but is also seen as a complication of other diseases and is also a recognised side effect of GLP-1 agonists used to treat diabetes and for ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may ...

The FDA recommended conducting two new, well-designed clinical trials in adults with idiopathic or diabetic gastroparesis to address the deficiencies and perform a long-term toxicity study in a ...

WASHINGTON, Jan. 8, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. Vanda Logo (PRNewsfoto/Vanda ...